These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6285809)

  • 1. Efficacy of ceftriaxone in serious bacterial infections.
    Epstein JS; Hasselquist SM; Simon GL
    Antimicrob Agents Chemother; 1982 Mar; 21(3):402-6. PubMed ID: 6285809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of ceftriaxone.
    File TM; Tan JS; Salstrom SJ
    Clin Ther; 1984; 6(5):653-61. PubMed ID: 6090021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftriaxone in the treatment of serious infections, particularly after surgery.
    Scully BE; Neu HC
    Am J Surg; 1984 Oct; 148(4A):35-40. PubMed ID: 6091479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone therapy of serious bacterial infections.
    Eron LJ; Park CH; Goldenberg RI; Poretz DM
    J Antimicrob Chemother; 1983 Jul; 12(1):65-78. PubMed ID: 6311783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of cefotaxime in serious infections.
    Karakusis PH; Feczko JM; Goodman LJ; Hanlon DM; Harris AA; Levin S; Trenholme GM
    Antimicrob Agents Chemother; 1982 Jan; 21(1):119-24. PubMed ID: 6282202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twice daily ceftriaxone therapy for serious bacterial infections in children.
    Chonmaitree T; Congeni BL; Munoz J; Rakusan TA; Powell KR; Box QT
    J Antimicrob Chemother; 1984 May; 13(5):511-6. PubMed ID: 6330022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone: therapeutic results in various infections and kinetic studies.
    Giamarellou HJ; Tsagarakis J; Petrikkos G; Mavroudis K; Veldekis D; Daikos GK
    Arzneimittelforschung; 1984; 34(3):321-5. PubMed ID: 6329238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections.
    Maslow MJ; Levine JF; Pollock AA; Simberkoff MS; Rahal JJ
    Antimicrob Agents Chemother; 1982 Jul; 22(1):103-7. PubMed ID: 6289735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftriaxone therapy of serious bacterial infections in adults.
    Bittner MJ; Dworzack DL; Preheim LC; Tofte RW; Crossley KB
    Antimicrob Agents Chemother; 1983 Feb; 23(2):261-6. PubMed ID: 6301365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone (Ro 13-9904) therapy of serious infection.
    Bradsher RW
    Antimicrob Agents Chemother; 1982 Jul; 22(1):36-42. PubMed ID: 6289739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin.
    Beskid G; Christenson JG; Cleeland R; DeLorenzo W; Trown PW
    Antimicrob Agents Chemother; 1981 Aug; 20(2):159-67. PubMed ID: 6269487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
    Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
    Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefmenoxime: clinical evaluation.
    Baker RL; Perkins RL
    Am J Med; 1984 Dec; 77(6A):53-9. PubMed ID: 6097126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone: in vitro studies and clinical evaluation.
    Gnann JW; Goetter WE; Elliott AM; Cobbs CG
    Antimicrob Agents Chemother; 1982 Jul; 22(1):1-9. PubMed ID: 6289734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
    Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
    Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of ceftriaxone in serious pediatric infections.
    Aronoff SC; Murdell D; O'Brien CA; Klinger JD; Reed MD; Blumer JL
    Antimicrob Agents Chemother; 1983 Nov; 24(5):663-6. PubMed ID: 6318653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone - a new broad-spectrum semisynthetic cephalosporin. In vitro activity against gram-negative bacilli sensitive and resistant to gentamicin.
    Bremner DA
    Chemotherapy; 1983; 29(4):283-8. PubMed ID: 6307605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settings.
    Eron LJ; Park CH; Hixon DL; Goldenberg RI; Poretz DM
    Antimicrob Agents Chemother; 1983 May; 23(5):731-7. PubMed ID: 6307135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone: in vitro activity against 410 bacterial isolates compared with cefotaxime.
    Digranes A; Benonisen E; Dibb WL
    Infection; 1982; 10(5):307-9. PubMed ID: 6293978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once daily ceftriaxone for central nervous system infections and other serious pediatric infections.
    Yogev R; Shulman ST; Chadwick EG; Davis AT; Glogowski W
    Pediatr Infect Dis; 1986; 5(3):298-303. PubMed ID: 3725639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.